S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:SDGR

Schrödinger (SDGR) Stock Price, News & Analysis

$25.04
+0.28 (+1.13%)
(As of 04/17/2024 ET)
Today's Range
$24.46
$25.54
50-Day Range
$24.74
$33.09
52-Week Range
$20.76
$59.24
Volume
487,846 shs
Average Volume
865,411 shs
Market Capitalization
$1.81 billion
P/E Ratio
39.75
Dividend Yield
N/A
Price Target
$43.50

Schrödinger MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
73.7% Upside
$43.50 Price Target
Short Interest
Bearish
8.63% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.59mentions of Schrödinger in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$102,395 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.73) to ($1.94) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.51 out of 5 stars

Medical Sector

261st out of 913 stocks

Pharmaceutical Preparations Industry

101st out of 397 stocks

SDGR stock logo

About Schrödinger Stock (NASDAQ:SDGR)

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

SDGR Stock Price History

SDGR Stock News Headlines

Schrödinger (NASDAQ:SDGR) Trading Down 7.7%
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
5 Healthcare Stocks to Buy for 2024
Invest Like Bill Gates With These 3 AI Stocks to Buy
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Shhh! 7 Small-Cap Stocks That Can Double by 2025
The Hot List: 3 AI Stocks Worth Buying on Weakness
Piper Sandler Keeps Their Buy Rating on Schrodinger (SDGR)
SDGR Jun 2024 20.000 call
SDGR Apr 2024 40.000 call
SDGR Jan 2025 65.000 put
SDGR Jan 2026 55.000 put
Double Your Money: 3 Growth Stocks to Grab in 2024
See More Headlines
Receive SDGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
4/17/2024
Next Earnings (Confirmed)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SDGR
Fax
N/A
Employees
867
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$43.50
High Stock Price Target
$67.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+72.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

Net Income
$40.72 million
Pretax Margin
19.81%

Debt

Sales & Book Value

Annual Sales
$216.67 million
Cash Flow
$0.63 per share
Book Value
$7.60 per share

Miscellaneous

Free Float
66,815,000
Market Cap
$1.82 billion
Optionable
Optionable
Beta
1.57
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Ramy Farid Ph.D. (Age 58)
    CEO, President & Director
    Comp: $1.04M
  • Dr. Richard A. Friesner Ph.D. (Age 71)
    Co-Founder, Scientific Advisory Chairman and Director
    Comp: $455k
  • Dr. Geoffrey Craig Porges MBBS
    Executive VP & CFO
  • Ms. Yvonne Tran Esq. (Age 53)
    Chief Legal & People Officer
    Comp: $670.1k
  • Dr. Robert Lorne Abel Ph.D. (Age 41)
    Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D
    Comp: $528.37k
  • Dr. Karen Akinsanya Ph.D. (Age 56)
    President of Research & Development Therapeutics
    Comp: $777.68k
  • Ms. Jenny Herman
    Senior VP of Finance & Corporate Controller
  • Prof. William Goddard III
    Co-Founder & Scientific Advisor
  • Mr. Kenneth Patrick Lorton (Age 40)
    Executive VP, CTO & COO of Software
    Comp: $510.09k
  • Mr. Shane Brauner (Age 46)
    Executive VP & Chief Information Officer

SDGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Schrödinger stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Schrödinger in the last twelve months. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SDGR shares.
View SDGR analyst ratings
or view top-rated stocks.

What is Schrödinger's stock price target for 2024?

9 analysts have issued 1 year price objectives for Schrödinger's shares. Their SDGR share price targets range from $26.00 to $67.00. On average, they predict the company's stock price to reach $43.50 in the next twelve months. This suggests a possible upside of 73.7% from the stock's current price.
View analysts price targets for SDGR
or view top-rated stocks among Wall Street analysts.

How have SDGR shares performed in 2024?

Schrödinger's stock was trading at $35.80 at the start of the year. Since then, SDGR shares have decreased by 30.1% and is now trading at $25.04.
View the best growth stocks for 2024 here
.

When is Schrödinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our SDGR earnings forecast
.

How can I listen to Schrödinger's earnings call?

Schrödinger will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Schrödinger's earnings last quarter?

Schrödinger, Inc. (NASDAQ:SDGR) released its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.44) by $0.12. The firm had revenue of $74.10 million for the quarter, compared to analyst estimates of $79.12 million. Schrödinger had a net margin of 18.79% and a negative trailing twelve-month return on equity of 23.58%. The firm's revenue was up 30.5% on a year-over-year basis. During the same period in the previous year, the business earned ($0.39) earnings per share.

What guidance has Schrödinger issued on next quarter's earnings?

Schrödinger issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $198.7 million-$214.8 million, compared to the consensus revenue estimate of $275.8 million.

What is Ramy Farid's approval rating as Schrödinger's CEO?

8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Schrödinger own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ), Cisco Systems (CSCO), Teladoc Health (TDOC), Alteryx (AYX) and QUALCOMM (QCOM).

When did Schrödinger IPO?

Schrödinger (SDGR) raised $150 million in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO.

Who are Schrödinger's major shareholders?

Schrödinger's stock is owned by a variety of institutional and retail investors. Top institutional investors include TrueMark Investments LLC (0.06%), Los Angeles Capital Management LLC (0.02%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include David E Shaw, Jenny Herman, Joel Lebowitz, Karen Akinsanya, Kenneth Patrick Lorton, Nancy Thornberry, Ramy Farid, Robert Lorne Abel, Rosana Kapeller-Libermann and Yvonne Tran.
View institutional ownership trends
.

How do I buy shares of Schrödinger?

Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SDGR) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners